36m agoThe FlyBULLISH 61Analyst
Why Is ALAMAR BIOSCIENCES I (ALMR) Stock Up Today?
By the Top Tier Newswire AI Desk · reviewed against 13 wire stories
ALAMAR BIOSCIENCES I (ALMR) is up +18.56% in the latest session. Our newswire has captured 13 stories on ALMR across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for ALMR publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
ALMR by the numbers
Last: $33.19Session: +18.56%Coverage: 13 stories / 4 sourcesAI sentiment: 58/100 (bullish)
The headlines behind the move
2h agoThe FlyBULLISH 63Analyst
Alamar Biosciences price target raised to $32 from $28 at Stifel
2h agoThe FlyBULLISH 63Analyst
Alamar Biosciences price target raised to $35 from $32 at JPMorgan
14h agoSeeking AlphaBULLISH 67Earnings
Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through
Alamar Biosciences (ALMR) Q2 2026 earnings call recap: 82% revenue growth, 60% gross margin, 2026 guidance and neurology partnerships—read the insights now.
14h agoSeeking AlphaNEUTRAL 50Earnings
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings Call Transcript
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings Call August 10, 2026 4:30 PM EDTCompany ParticipantsCarrie MendivilYuling Luo - Co-Founder, Chairman &...
16h agoSeeking AlphaNEUTRAL 50Earnings
Alamar Biosciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-10. The following slide deck was published by Alamar Biosciences, Inc.
16h agoThe FlyBULLISH 63Product/PR
Alamar Biosciences Expands Alzheimers Data Initiative Deal With 86k Samples
17h agoThe FlyBULLISH 63Earnings
Alamar Biosciences Sees Fy26 Revenue 116m 120m Consensus 113 22m
17h agoThe FlyBEARISH 34Earnings
Alamar Biosciences reports Q2 EPS (22c), consensus (32c)
17h agoSeeking AlphaBULLISH 68Earnings
Alamar Biosciences, Inc. GAAP EPS of -$0.22 beats by $0.11, revenue of $29.4M beats by $3.46M
Alamar Biosciences (ALMR) Q2 2026 earnings: EPS and revenue beat, gross margin rises to 60%, and 2026 revenue guidance updated—read key takeaways.
Frequently asked questions
Why is ALMR stock up today?
ALAMAR BIOSCIENCES I (ALMR) is up +18.56% in the latest session. Our newswire has captured 13 stories on ALMR across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "Alamar Biosciences price target raised to $31 from $30 at BofA" (The Fly).
Is ALMR a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ALMR coverage reads 58/100 over 13 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is NIQ up today (+31.85%)
- Why is LIF down today (-25.85%)
- Why is ONON down today (-20.55%)
- Why is FRMI up today (+20.24%)
- Why is RNW up today (+11.01%)
- Why is FA down today (-10.94%)
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on ALMR: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.